DV
Therapeutic Areas
Sapu BioScience Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OT-101 | Relapsed/Refractory Cancers (including DIPG) | Clinical Trial (Phase not specified) |
| Drug | Indication | Phase |
|---|---|---|
| OT-101 | Relapsed/Refractory Cancers (including DIPG) | Clinical Trial (Phase not specified) |